Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Atea Pharmaceuticals, Inc. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
F
FMR LLC
|
12.0M | 14.97% | +53.3K (+0.4%) | ≤2021 | 0.0% | |
|
Shares held by quarter
Peak holding12.0M (Q2'26)
Change over 8 quarters+5.4M
Share of the company14.970%
|
||||||
|
B
BlackRock, Inc.
|
8.7M | 10.87% | +284.6K (+3.4%) | ≤2021 | 0.0% | |
|
Shares held by quarter
Peak holding9.1M (Q4'24)
Change over 8 quarters−270.7K
Share of the company10.870%
|
||||||
28 more super investors behind a free account
See every manager holding Atea Pharmaceuticals, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
FG
Fidelity Mt. Vernon Street Trust
|
$16.7M | 3.1M | 3.90% | 0.02% | August 31, 2026 |
|
VT
Vanguard Index Funds
|
$9.45M | 2.0M | 2.53% | 0.00% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Atea Pharmaceuticals, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
SJ
Sommadossi Jean-Pierre
Insider
|
6.6M | 8.27% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company8.270%
|
||||||
|
RB
Radoff Bradley Louis
5%+ holder
13D · 4.0%
|
3.4M | 4.21% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
17 more holders behind a free account
See every insider and 5%+ holder of Atea Pharmaceuticals, Inc..
Sign up freeLoading...
